Selective LC-MS/MS method for simultaneous plasma determination of imatinib, dasatinib, nilotinib, bosutinib, ponatinib and ibrutinib based on effective phospholipids removing clean-up method: application to therapeutic drug monitoring
validated for simultaneous quantification of five tirosine kinase inhibitors (imatinib, dasatinib, nilotinib, bosutinib, ponatinib) and one BrutonâÂ?Â?s tyrosine kinase inhibitor (ibrutinib) in human plasma. Stable…

